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   Determination of glomerular filtration rate (GFR) is the most reliable test to evaluate kidney 
function. Many plasma clearance markers can be used to estimate GFR, though recently 
iohexol and creatinine have been proposed as easily applicable clearance markers. A previous 
preliminary study suggested differences between clearance techniques to be related to the 
range of GFR estimate (van Hoek et al., JFMS 2009;11:1028-1030). This study aimed to 
compare plasma creatinine, exo-iohexol and endo-iohexol clearance tests in a larger 
population of cats with low, normal and high GFRs.  
 
   Healthy cats and cats with hyperthyroidism (HT), diabetes mellitus (DM) and chronic 
kidney disease (CKD) that underwent a plasma exogenous creaitinine-iohexol clearance test 
(PEC-ICT) at the University of Ghent were considered for inclusion. The PEC-ICT was 
performed as described by van Hoek et al. (JVIM 2007;21:950-958). Cats were included only 
once if multiple PEC-ICTs were performed at different time points. The effect of health status 
on GFR was evaluated with a general linear model. A general linear model and Bland-Altman 
plots were used to compare GFR estimates according to the used clearance marker. All tests 
were performed with statistical software (Systat) and at the 5% significance level. 
 
   Forty-four cats were included and divided into 5 groups: 16 untreated HT cats, 6 DM cats, 
10 CKD cats (6 were previously treated for HT, 1 cat had both CKD and DM), 6 young (7-12 
months) healthy cats and 6 old (9-12 years) healthy cats. The mean GFR (expressed in 
mL/kg/min) was 2.33 ± 1.29 for exo-iohexol, 2.63 ± 1.39 for endo-iohexol and 2.65 ± 1.36 for 
creatinine clearance. The GFR estimates were significantly lower (P<0.001) in the CKD group 
and higher (P<0.001) in the HT group than in the other groups. A significant effect (P<0.001) 
of the clearance marker on the GFR estimate was observed in healthy (young and old) and 
CKD cats, but not in HT and DM cats. The number of cats showing a difference in GFR 
estimate of >0.5mL/min/kg or >25% was 17/44 and 14/44 between plasma creatinine and exo-
iohexol clearance, 20/44 and 19/44 between plasma endo-iohexol and creatinine clearance and 
25/44 and 19/44 between plasma endo- and exo-iohexol clearance, respectively. The Bland-
Altman plots comparing endo-iohexol with the other 2 markers showed the largest 
discrepancies. Plasma creatinine clearance values were most often higher than those for exo-
iohexol. 
 
   In conclusion, discrepancies between GFR testing methods may exist according to the 
clinical status of the animal. It is therefore recommended to use the same method during a 
patient’s follow-up and separate cut-off values for each marker.  
